Featured Research

from universities, journals, and other organizations

Freshwater polyp hydra genome sequenced: Survey finds genes linked to Huntington's, Alzheimer's

Date:
March 15, 2010
Source:
University of California - Irvine
Summary:
An international team of scientists have sequenced the genome of Hydra, a freshwater polyp that's been a staple of biological research for 300 years.

This photo of Hydra was taken in a Newport Beach, Calif., stream.
Credit: Peter Bryant / UC Irvine

UC Irvine researchers have played a leading role in the genome sequencing of Hydra, a freshwater polyp that has been a staple of biological research for 300 years.

In the March 14 online version of Nature, UCI biologists Robert Steele and Hans Bode, along with nine other UCI scientists and an international team of researchers, describe the genome sequence of an organism that continues to advance research on regeneration, stem cells and patterning.

The team discovered Hydra to have about the same number of genes as humans, sharing many of the same ones. Surprisingly, they also found genes linked with Huntington's disease and with the beta-amyloid plaque formation seen in Alzheimer's disease -- two areas in which UCI has traditionally strong research programs -- suggesting the possible use of Hydra as a research model for these two diseases.

"Having the Hydra genome sequenced also enhances our ability to use it to learn more about the basic biology of stem cells, which are showing great promise for new treatments for a host of injuries and diseases," said Steele, associate professor and interim chair in biological chemistry.

Started in 2004, the Hydra project is the first genome sequencing effort in which UCI scientists have played a major role. The sequencing was carried out at the J. Craig Venter Institute and was funded by the National Human Genome Research Institute.


Story Source:

The above story is based on materials provided by University of California - Irvine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Chapman et al. The dynamic genome of Hydra. Nature, 2010; DOI: 10.1038/nature08830

Cite This Page:

University of California - Irvine. "Freshwater polyp hydra genome sequenced: Survey finds genes linked to Huntington's, Alzheimer's." ScienceDaily. ScienceDaily, 15 March 2010. <www.sciencedaily.com/releases/2010/03/100314150922.htm>.
University of California - Irvine. (2010, March 15). Freshwater polyp hydra genome sequenced: Survey finds genes linked to Huntington's, Alzheimer's. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/03/100314150922.htm
University of California - Irvine. "Freshwater polyp hydra genome sequenced: Survey finds genes linked to Huntington's, Alzheimer's." ScienceDaily. www.sciencedaily.com/releases/2010/03/100314150922.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins